
Laura Shawver, Capstan Therapeutics CEO
AbbVie bags Capstan’s in vivo CAR-T work with $2.1B buyout deal
Almost three years ago, longtime biotech vet Laura Shawver cheerfully heralded the arrival of her latest startup with a colorful observation on the confluence of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.